Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-2 of 2
Keywords: osteoprotegerin (OPG)
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2006) 110 (3): 279–291.
Published: 10 February 2006
... apoptosis bone turnover metastatic bone disease osteoprotegerin (OPG) receptor activator of nuclear factor κB ligand (RANKL) tumour cell survival tumour-induced bone disease OPG (osteoprotegerin), a novel secreted member of the TNFR [TNF (tumour necrosis factor) receptor] super-family...
Articles
Alessandra Crisafulli, Antonio Micari, Domenica Altavilla, Francesco Saporito, Aurora Sardella, Maria Passaniti, Santi Raffa, Gaspare D'Anneo, Fabiana Lucà, Chiara Mioni, Francesco Arrigo, Francesco Squadrito
Journal:
Clinical Science
Clin Sci (Lond) (2005) 109 (4): 389–395.
Published: 23 September 2005
... of Messina, Italy (email crisafulli@jumpy.it ). 10 2 2005 27 5 2005 31 5 2005 31 5 2005 The Biochemical Society 2005 acute myocardial infarction coronary artery disease osteoprotegerin (OPG) RANKL (receptor activator of nuclear factor κB ligand) Atherosclerosis...
